Literature DB >> 12545532

Quantitative estimation of viral fitness using Pyrosequencing.

Frederick C Lahser1, Jacquelyn Wright-Minogue, Angela Skelton, Bruce A Malcolm.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12545532     DOI: 10.2144/03341bm01

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


× No keyword cloud information.
  6 in total

Review 1.  Pyrosequencing: sequence typing at the speed of light.

Authors:  Matthew A Diggle; Stuart C Clarke
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

2.  In vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants.

Authors:  Xiaodong Zhao; Enmei Liu; Fu-Ping Chen; Wayne M Sullender
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

3.  Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034).

Authors:  Mike Flint; Stanley Mullen; Anne M Deatly; Wei Chen; Lynn Z Miller; Robert Ralston; Colin Broom; Emilio A Emini; Anita Y M Howe
Journal:  Antimicrob Agents Chemother       Date:  2008-10-20       Impact factor: 5.191

4.  Conserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibition.

Authors:  Wenyan Wang; Frederick C Lahser; MinKyung Yi; Jacquelyn Wright-Minogue; Ellen Xia; Patricia C Weber; Stanley M Lemon; Bruce A Malcolm
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

5.  Pyrosequencing trade mark : A one-step method for high resolution HLA typing.

Authors:  Daniel Ramon; Megan Braden; Sharon Adams; Francesco M Marincola; Lu Wang
Journal:  J Transl Med       Date:  2003-11-26       Impact factor: 5.531

6.  Characterization of San Miguel sea lion virus populations using pyrosequencing-based methods.

Authors:  James F X Wellehan; Fahong Yu; Stephanie K Venn-Watson; Eric D Jensen; Cynthia R Smith; William G Farmerie; Hendrik H Nollens
Journal:  Infect Genet Evol       Date:  2009-12-01       Impact factor: 3.342

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.